Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Neurosci Biobehav Rev ; 102: 95-105, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-30959072

RESUMO

The impact of neurodegenerative disorders in humans has multiple consequences because of the progressive decline in cognitive and physical performances. These disorders have diverse manifestations and are influenced by genetic and lifestyle factors, concurrent health conditions as well as un-modifiable predisposing risk factors, including gender and advanced age. Accumulating evidence indicates a gender-dependent natural bias of neurodegenerative diseases, such as, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis, with the ratio of male to female prevalence as well as the severity of the disease differing significantly between the two sexes. This observation has recently garnered much attention and it is now being realized that understanding the sex as a biological variable in the etiology of the neurodegenerative diseases may advance the status of the pathophysiology and treatment strategies while improving the associated decline in cognitive and functional abilities. This review highlights the influence of gender in neurodegenerative disorders and further discusses the sex-specific pre-determined microenvironments that are critical in predisposing the individuals to such disorders.


Assuntos
Doença de Alzheimer/fisiopatologia , Encéfalo/fisiopatologia , Epigênese Genética/fisiologia , Doença de Huntington/fisiopatologia , Mitocôndrias/fisiologia , Esclerose Múltipla/fisiopatologia , Doença de Parkinson/fisiopatologia , Caracteres Sexuais , Fatores Sexuais , Doença de Alzheimer/epidemiologia , Doença de Alzheimer/metabolismo , Encéfalo/metabolismo , Humanos , Doença de Huntington/epidemiologia , Doença de Huntington/metabolismo , Mitocôndrias/metabolismo , Esclerose Múltipla/epidemiologia , Esclerose Múltipla/metabolismo , Doença de Parkinson/epidemiologia , Doença de Parkinson/metabolismo
2.
Int J Biochem Cell Biol ; 38(12): 2074-81, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16861029

RESUMO

Several decades back ascorbic acid was proposed as an effective anticancer agent. However, this idea remained controversial and the mechanism of action unclear. In this paper, we show that ascorbic acid at a concentration reported to be achievable through high doses of oral consumption is capable of cytotoxic action against normal cells. Several antioxidants of both animal as well as plant origin including ascorbic acid also possess prooxidant properties. Copper is an essential component of chromatin and can take part in redox reactions. Previously we have proposed a mechanism for the cytotoxic action of plant antioxidants against cancer cells that involves mobilization of endogenous copper ions and the consequent generation of reactive oxygen species. Using human peripheral lymphocytes and Comet assay we show here that ascorbic acid is able to cause oxidative DNA breakage in normal cells at a concentration of 100-200 microM. Neocuproine, a Cu(I) specific sequestering agent inhibited DNA breakage in a dose dependent manner indicating that Cu(I) is an intermediate in the DNA cleavage reaction. The results are in support of our above hypothesis that involves events that lead to a prooxidant action by antioxidants. The results would support the idea that even a plasma concentration of around 200 microM. would be sufficient to cause pharmacological tumor cell death particularly when copper levels are elevated. This would account for the observation of several decades back by Pauling and co-workers where oral doses of ascorbic acid in gram quantities were found to be effective in treating some cancers.


Assuntos
Ácido Ascórbico/farmacologia , Ácido Ascórbico/toxicidade , Cobre/metabolismo , Dano ao DNA/efeitos dos fármacos , Linfócitos/efeitos dos fármacos , Linfócitos/metabolismo , Antineoplásicos/farmacologia , Antioxidantes/farmacologia , Ensaio Cometa , Dano ao DNA/genética , Ensaios de Seleção de Medicamentos Antitumorais , Sequestradores de Radicais Livres/farmacologia , Humanos , Peróxido de Hidrogênio/metabolismo , Neoplasias/genética , Neoplasias/patologia , Oxidantes/farmacologia , Oxidantes/toxicidade , Oxirredução/efeitos dos fármacos , Fenantrolinas/farmacologia , Taninos/farmacologia
3.
FEBS Lett ; 580(2): 533-8, 2006 Jan 23.
Artigo em Inglês | MEDLINE | ID: mdl-16412432

RESUMO

Plant polyphenols are important components of human diet and a number of them are considered to possess chemopreventive and therapeutic properties against cancer. They are recognized as naturally occurring antioxidants but also act as prooxidants catalyzing DNA degradation in the presence of transition metal ions such as copper. Using human peripheral lymphocytes and Comet assay we have previously confirmed that resveratrol-Cu(II) is indeed capable of causing DNA degradation in cells. In this paper we show that the polyphenols alone (in the absence of added copper) are also capable of causing DNA breakage in cells. Incubation of lymphocytes with neocuproine inhibited the DNA degradation confirming that Cu(I) is an intermediate in the DNA cleavage reaction. Further, we have also shown that polyphenols generate oxidative stress in lymphocytes which is inhibited by scavengers of reactive oxygen species and neocuproine. These results are in further support of our hypothesis that anticancer mechanism of plant polyphenols involves mobilization of endogenous copper, possibly chromatin bound copper, and the consequent prooxidant action.


Assuntos
Antineoplásicos/metabolismo , Cobre/metabolismo , Dano ao DNA , Flavonoides/metabolismo , Linfócitos/metabolismo , Estresse Oxidativo , Fenóis/metabolismo , Extratos Vegetais/química , Antioxidantes/metabolismo , Antioxidantes/farmacologia , Quelantes/metabolismo , Ensaio Cometa , Flavonoides/farmacologia , Ácido Gálico/metabolismo , Ácido Gálico/farmacologia , Humanos , Linfócitos/efeitos dos fármacos , Oxirredução , Fenantrolinas/metabolismo , Fenóis/farmacologia , Polifenóis , Resveratrol , Estilbenos/metabolismo , Estilbenos/farmacologia , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo
4.
FEBS Lett ; 579(14): 3131-5, 2005 Jun 06.
Artigo em Inglês | MEDLINE | ID: mdl-15919081

RESUMO

Resveratrol (3,4',5-trihydroxy stilbene), a plant derived polyphenol found in mulberries, grapes and red wine is considered to possess chemopreventive properties against cancer. It is recognized as a naturally occurring antioxidant but also catalyzes oxidative DNA degradation in vitro in the presence of transition metal ions such as copper. Using a cellular system of lymphocytes isolated from human peripheral blood and Comet assay, we have confirmed that resveratrol-Cu(II) system is indeed capable of causing DNA degradation in cells such as lymphocytes. Also, trans-stilbene, which does not have any hydroxyl groups, is inactive in the lymphocyte system. Pre-incubation of lymphocytes with resveratrol indicates that it is capable of either traversing the cell membrane or binding to it. Our results are in partial support of our hypothesis that anticancer properties of various plant derived polyphenols may involve mobilization of endogenous copper and the consequent prooxidant action.


Assuntos
Antineoplásicos/farmacologia , Cobre/farmacologia , Dano ao DNA/efeitos dos fármacos , DNA/efeitos dos fármacos , DNA/metabolismo , Linfócitos/efeitos dos fármacos , Estilbenos/farmacologia , Antineoplásicos/química , Ensaio Cometa , Cobre/química , DNA/genética , Humanos , Linfócitos/citologia , Linfócitos/metabolismo , Estrutura Molecular , Plasmídeos/genética , Espécies Reativas de Oxigênio/metabolismo , Resveratrol , Estilbenos/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...